Glatiramyl 20 mg/ml

Glatiramyl 20 mg/ml is a medicine authorised by Swissmedic under authorisation number 65626. The authorisation holder is Viatris Pharma GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 05 July 2016 and the authorisation is valid without a time limit. ATC code L03AX13 places the medicine in the group Immunostimulants.

  • Dispensing category B
  • Authorisation number 65626
  • ATC L03AX13
  • Synthetic medicines
Authorisation data
Authorisation number65626
NameGlatiramyl 20 mg/ml
Full nameGlatiramyl 20 mg/ml, Injektionslösung in einer Fertigspritze
Authorisation holderViatris Pharma GmbH
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeL03AX13
First authorisation05 July 2016
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Glatiramyl 20 mg/ml, Injektionslösung in einer FertigspritzeB05 July 2016

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
128Fertigspritze(n)L03AX1301.99.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Glatiramyl 20 mg/ml authorised in Switzerland?

Yes. Glatiramyl 20 mg/ml is authorised by Swissmedic under authorisation number 65626, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Glatiramyl 20 mg/ml have?

Glatiramyl 20 mg/ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Glatiramyl 20 mg/ml?

The authorisation holder is Viatris Pharma GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com